- It typically takes about ten times longer to develop an experimental vaccine. Human trials began in March.
- The vaccine uses messenger RNA , a new technology that delivers the virus's DNA code to cells so the body can fight off the virus itself.
- Moderna hopes to have the vaccine ready by fall 2020 for emergency use , which could include use for health professionals, Bancel has said .
- Forbes estimates that Bancel is now worth around $1 billion since he owns about 9% of Moderna, and the company is valued at more than $11 billion .
- Visit Business Insider's homepage for more stories .
ADVERTISEMENT
Meet Stéphane Bancel, the CEO of Moderna, a company developing a coronavirus vaccine in record time, who just became a billionaire
Stphane Bancel is the CEO of Moderna , the company that translated the genetic code of the coronavirus into a vaccine in a record-breaking 42 days.
Stephane Bancel
ADVERTISEMENT
Stphane Bancel is the CEO of Moderna, a Massachusetts-based biotech company that is working on a coronavirus vaccine.
BusinessInsider USA Images
Source: Business Insider
ADVERTISEMENT
Forbes estimates that Bancel's net worth grew to around $1 billion after Moderna stocks jumped by 12% in the first week of April. This closely followed the news that they expect to start a mid-stage study of its coronavirus vaccine in a few months. Bancel owns about 9% of the company.
BusinessInsider USA Images
While vaccines typically work by giving a patient a tiny bit of the virus they're trying to kill, Moderna's coronavirus vaccine uses just the ribonucleic acid (RNA) genetic material from the virus. The RNA gives the body the genetic information of the virus so it can create the proteins it needs to heal itself.
BusinessInsider USA Images
ADVERTISEMENT
Source: Business Insider , Axios
The method of using just the genetic material of a virus for a vaccine is part of Bancel's vision for Moderna, which he says can be applied to vaccines for viruses other than the coronavirus.
BusinessInsider USA Images
Source: Business Insider
The method allows for quicker and lower-cost vaccine development, according to Bancel. Moderna translated the genetic code of the novel coronavirus into a vaccine in 42 days. Comparatively, after the 2002-2003 SARS outbreak, it took 20 months to begin testing a vaccine.
ADVERTISEMENT
BusinessInsider USA Images
Source: Business Insider
The technology is called messenger RNA, and it's still is an unproven technology. There are no FDA-approved drugs or vaccines coming from it yet, and Moderna has no approved drugs or vaccines.
BusinessInsider USA Images
Source: Business Insider
ADVERTISEMENT
Moderna was founded in 2010 to make messenger-RNA-based drugs. The company has 21 messenger-RNA-based drugs in the works, and 10 of them are in clinical trials.
BusinessInsider USA Images
Source: Chemical & Engineering News , Business Insider
Bancel joined Moderna in 2011. Before that, he was the CEO of a French diagnostics company called BioMrieux.
BusinessInsider USA Images
ADVERTISEMENT
Source: Forbes
At BioMrieux, Bancel developed a reputation as a strict manager. An equities analyst who covered the company during Bancel's tenure told STAT, "I think if you're underperforming, you'll probably find yourself looking for another job."
BusinessInsider USA Images
Source: STAT
Bancel grew up in France. He has an MBA from Harvard Business School and two master's degrees in engineering from cole Centrale Paris and the University of Minnesota.
ADVERTISEMENT
BusinessInsider USA Images
Source: Forbes
The vaccine, which Moderna hopes to have ready for emergency use in the fall, is now being tested by healthy volunteers in clinical trials in Seattle and Atlanta. The first volunteer received a dose of the vaccine on March 16.
BusinessInsider USA Images
Source: Business Insider
ADVERTISEMENT
Bancel told Business Insider he expects to get data about the safety of the vaccine in the spring, and he expects to get data showing how well the vaccine triggers an immune response, known as immunogenicity, in the late spring or early summer.
BusinessInsider USA Images
Source: Business Insider
See Also:
- 14 countries that are paying their workers during quarantine and how they compare to America's $1,200 stimulus checks
- A former Department of Defense official says one particular piece of legislation could help America rebuild its supply chains and rely less on China, calling this a national imperative here's how it would work
- 8 nonprofits you can donate your stimulus check to that are helping Americans struggling because of the coronavirus pandemic
ADVERTISEMENT
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
Russia spreads its military influence to another African country
A look into South Korea’s rice gift to Africa
FBNBank Ghana changes to FirstBank Ghana to align with group identity
Nigeria restricts power export to neighbouring countries to meet domestic demand
NOG Energy Week 2024: West African countries harnessing gas for industrialisation to boost economic development
10 African countries with the smallest labor force
West Africa healthcare and pharmaceutical landscapes gets a boost: A look back at Medlab & Pharmaconex
10 countries with the most stressed workers in Africa